Home › Companies › ANAPTYSBIO INC. › 2023-2024
Compiled from SEC Form N-PX filings and ANAPTYSBIO INC.’s Form 8-K, filed 2024-06-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024 2024-2025
Explore ANAPTYSBIO INC. in the interactive database Compare manager voting policies
These tallies are ANAPTYSBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Daniel Faga | 22,287,039 | -- | 545,311 | 545,311 | 1,943,741 | Majority: yes |
| Elect Director: Dennis Fenton, Ph.D. | 21,883,756 | -- | 948,594 | 948,594 | 1,943,741 | Majority: yes |
| Elect Director: Oleg Nodelman | 18,793,914 | -- | 3,885,244 | 3,885,244 | 2,096,933 | Majority: yes |
| Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024: | 24,744,224 | 30,261 | 1,606 | 1,606 | -- | Majority: yes |
| Proposal 3: Non-binding, advisory approval of compensation paid to the Company's named executive officers: | 19,874,097 | 2,954,956 | 3,397 | 3,397 | 1,943,641 | Majority: yes |
| Proposal 4: Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan: | 16,839,857 | 4,686,098 | 1,306,496 | 1,306,496 | 1,943,640 | Majority: yes |
Source: ANAPTYSBIO INC., Form 8-K, filed with the SEC on 2024-06-12 — read the filing on EDGAR.
Each item below shows how the 169 asset managers that disclosed a ANAPTYSBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Proposal 3: Non-binding, advisory approval of compensation paid to the Company's named executive officers:”): 19,874,097 for, 2,954,956 against, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 73% for, 11% against (84% of the company cast a for/against vote).
The 168 asset managers below cast 86% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 7,521,024 | 0 | 0 | 0 | For |
| State Street | 1,841,861 | 27,796 | 0 | 0 | For |
| BlackRock | 1,518,377 | 8,872 | 0 | 0 | For |
| Vanguard | 1,356,137 | 0 | 0 | 0 | For |
| Boxer Capital, LLC | 1,285,217 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 910,546 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 886,371 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 803,641 | 0 | 0 | 0 | For |
| Fidelity | 401,935 | 280,327 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 465,373 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 454,434 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 422,517 | 0 | 0 | 0 | For |
| Woodline Partners LP | 398,966 | 0 | 0 | 0 | For |
| Dimensional | 0 | 365,513 | 0 | 0 | Against |
| 5AM Venture Management, LLC | 357,733 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 0 | 355,906 | 0 | 0 | Against |
| Saturn V Capital Management LP | 321,043 | 0 | 0 | 0 | For |
| Charles Schwab | 292,812 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 258,808 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Northern Trust | 160,153 | 308 | 0 | 0 | For |
| Two Sigma | 0 | 153,099 | 0 | 0 | Against |
| Hudson Bay Capital Management LP | 0 | 122,864 | 0 | 0 | Against |
| UBS | 0 | 111,673 | 0 | 0 | Against |
Showing the 25 largest of 168 asset managers. See all 168 in the interactive database.
Combines 2 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Proposal 4: Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan:”): 16,839,857 for, 4,686,098 against, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 62% for, 17% against (79% of the company cast a for/against vote).
The 56 asset managers below cast 69% of the shares they voted on this item FOR (5,185,968 for, 2,278,531 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 886,371 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 803,641 | 0 | 0 | 0 | For |
| State Street | 8,007 | 733,984 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 5,355 | 536,237 | 0 | 0 | Against |
| Saturn V Capital Management LP | 321,043 | 0 | 0 | 0 | For |
| Dimensional | 0 | 287,176 | 0 | 0 | Against |
| T. Rowe Price | 0 | 201,426 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 124,134 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 93,732 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 70,688 | 0 | 0 | Against |
| Equitable | 32,456 | 30,630 | 0 | 0 | For |
| TIAA | 0 | 52,595 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 20,298 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 18,602 | 0 | 0 | Against |
| ProShares | 0 | 17,961 | 0 | 0 | Against |
| John Hancock | 0 | 14,627 | 0 | 0 | Against |
| Nushares ETF Trust | 0 | 11,106 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 9,232 | 0 | 0 | Against |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Daniel Faga”): 22,287,039 for, 545,311 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 82% for, 2% withheld (84% of the company cast a for/withheld vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (5,009,403 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 741,160 | 0 | 831 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,964 | 0 | 139,628 | 0 | For |
| Dimensional | 0 | 0 | 287,176 | 0 | Abstain |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 63,086 | 0 | 0 | 0 | For |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,600 | 0 | 3,698 | 0 | For |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 14,627 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 7,129 | 0 | Abstain |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Dennis Fenton, Ph.D.”): 21,883,756 for, 948,594 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 80% for, 3% withheld (84% of the company cast a for/withheld vote).
The 52 asset managers below cast 100% of the shares they voted on this item FOR (4,706,846 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 741,160 | 0 | 831 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,964 | 0 | 139,628 | 0 | For |
| Dimensional | 0 | 0 | 287,176 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 201,426 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 32,456 | 0 | 30,630 | 0 | For |
| TIAA | 0 | 0 | 52,595 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,600 | 0 | 3,698 | 0 | For |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 7,827 | 0 | 6,800 | 0 | For |
| Nushares ETF Trust | 0 | 0 | 11,106 | 0 | Abstain |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 7,129 | 0 | Abstain |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 4 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Elect Director: Oleg Nodelman”): 18,793,914 for, 3,885,244 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 69% for, 14% withheld (83% of the company cast a for/withheld vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (3,682,323 for, 85 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 8,007 | 0 | 733,984 | 0 | Abstain |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 401,935 | 0 | 139,657 | 0 | For |
| Dimensional | 0 | 0 | 287,176 | 0 | Abstain |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 146,406 | 0 | Abstain |
| Victory Capital | 0 | 0 | 124,134 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 93,732 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 70,688 | 0 | Abstain |
| Equitable | 34,756 | 0 | 28,330 | 0 | For |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 20,298 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 18,602 | 0 | Abstain |
| ProShares | 0 | 0 | 17,961 | 0 | Abstain |
| John Hancock | 6,800 | 0 | 7,827 | 0 | Abstain |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 9,232 | 0 | Abstain |
| Global X | 0 | 0 | 8,602 | 0 | Abstain |
| Jackson National | 0 | 0 | 7,129 | 0 | Abstain |
| SEI | 0 | 0 | 7,100 | 0 | Abstain |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
ANAPTYSBIO INC.’s own tally for this item (“Proposal 2: Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:”): 24,744,224 for, 30,261 against, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 27,316,644 outstanding shares: 91% for, 0.2% against (91% of the company cast a for/against vote).
The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (5,452,172 for, 1,272 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,313,911 | 0 | 0 | 0 | For |
| BlackRock | 838,960 | 0 | 0 | 0 | For |
| State Street | 740,719 | 1,272 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 568,324 | 0 | 0 | 0 | For |
| Fidelity | 541,592 | 0 | 0 | 0 | For |
| Dimensional | 287,176 | 0 | 0 | 0 | For |
| T. Rowe Price | 201,426 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 160,679 | 0 | 0 | 0 | For |
| Charles Schwab | 146,406 | 0 | 0 | 0 | For |
| Victory Capital | 124,134 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 70,688 | 0 | 0 | 0 | For |
| Equitable | 63,086 | 0 | 0 | 0 | For |
| TIAA | 52,595 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 35,735 | 0 | 0 | 0 | For |
| Federated Hermes | 35,552 | 0 | 0 | 0 | For |
| Lincoln Financial | 20,298 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 18,602 | 0 | 0 | 0 | For |
| ProShares | 17,961 | 0 | 0 | 0 | For |
| John Hancock | 14,627 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 11,106 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,232 | 0 | 0 | 0 | For |
| Global X | 8,602 | 0 | 0 | 0 | For |
| Jackson National | 7,129 | 0 | 0 | 0 | For |
| SEI | 7,100 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Ranked by the number of ANAPTYSBIO INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 27,316,644 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 27.53% |
| 2 | State Street | 6.84% |
| 3 | BlackRock | 5.59% |
| 4 | Vanguard | 4.96% |
| 5 | Boxer Capital, LLC | 4.70% |
| 6 | GREAT POINT PARTNERS LLC | 3.33% |
| 7 | First Light Asset Management, LLC | 3.24% |
| 8 | Palo Alto Investors LP | 2.94% |
| 9 | Fidelity | 2.50% |
| 10 | MUTUAL FUND SERIES TRUST | 2.08% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| EcoR1 Capital LLC | 27.53% | DEF14A |
| Oleg Nodelman | 27.53% | DEF14A |
| Deep Track Capital, LP | 7.46% | DEF14A |
| Tang Capital Partners, L.P. | 7.14% | DEF14A |
| BlackRock | 6.31% | 13F |
| Morgan Stanley | 5.70% | 13F |
| Vanguard Group | 5.41% | 13F |
| State Street | 4.42% | 13F |
| Point72 | 3.16% | 13F |
| Millennium Management | 2.37% | 13F |
Percentages above are of 27,316,644 shares outstanding, as reported by ANAPTYSBIO INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANAPTYSBIO INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ANAPTYSBIO INC.'s shareholder meeting held 2024-06-12, in the 2023-2024 proxy season, 169 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,122 separate fund positions. On the most widely held item on that ballot — TO CONDUCT A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS… — FOR was 87% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANAPTYSBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-12.
ANAPTYSBIO INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.